Income Statement
Balance Sheet
Cash Flow
| Line Item | FY 2024Dec 31, 2024 | FY 2023Dec 31, 2023 | FY 2022Dec 31, 2022 | FY 2021Dec 31, 2021 |
|---|---|---|---|---|
| Total Revenue | 5.4M | 4.3M | 5.9M | 3.2M |
| Operating Revenue | 5.4M | 4.3M | 5.9M | 3.2M |
| Cost Of Revenue | 2.5M | 2.9M | 1.6M | 1.3M |
| Gross Profit | 2.9M | 1.3M | 4.3M | 2.0M |
| Selling General And Administration | 1.0M | 876,621 | 858,389 | 634,765 |
| General And Administrative Expense | 1.0M | 876,621 | 858,389 | 634,765 |
| Research And Development | 1,062 | 6,654 | 140,000 | 0.00 |
| Other Operating Expenses | 1.6M | 1.2M | 2.0M | 1.4M |
| Operating Expense | 2.7M | 2.0M | 3.0M | 2.1M |
| Operating Income | 190,641 | -697,891 | 1.3M | -89,702 |
| EBIT | -4.3M | -1.7M | 1.4M | 1.0M |
| Interest Expense | 7,992 | 14,933 | 565.00 | 19,804 |
| Interest Expense Non Operating | 7,992 | 14,933 | 565.00 | 19,804 |
| Interest Income | -- | 0.00 | 80,448 | 0.00 |
| Interest Income Non Operating | -- | 0.00 | 80,448 | 0.00 |
| Net Interest Income | -10,241 | -16,624 | 77,191 | -21,619 |
| Other Income Expense | -4.5M | -983,000 | -204.00 | 1.1M |
| Other Non Operating Income Expenses | -- | -- | -- | 40,000 |
| Special Income Charges | -4.5M | -983,000 | 0.00 | 1.1M |
| Gain On Sale Of Security | -- | -- | -204.00 | -874.00 |
| Pretax Income | -4.3M | -1.7M | 1.4M | 1.0M |
| Tax Provision | 0.00 | 0.00 | -186,294 | 186,294 |
| Tax Effect Of Unusual Items | 0.00 | 0.00 | -53.47 | 199,457 |
| Net Income From Continuing And Discontinued Operation | -4.3M | -1.7M | 1.6M | 823,113 |
| Net Income From Continuing Operation Net Minority Interest | -4.3M | -1.7M | 1.6M | 823,113 |
| Net Income Including Noncontrolling Interests | -4.3M | -1.7M | 1.6M | 823,113 |
| Net Income Common Stockholders | -4.3M | -1.7M | 1.6M | 823,113 |
| Net Income | -4.3M | -1.7M | 1.6M | 823,113 |
| EBITDA | -2.4M | -36,169 | 2.8M | 2.1M |
| Normalized EBITDA | 2.0M | 946,831 | 2.8M | 1.1M |
| Reconciled Depreciation | 1.8M | 1.6M | 1.4M | 1.1M |
| Basic EPS | -0.01 | 0.00 | 0.00 | 0.00 |
| Diluted EPS | -0.01 | 0.00 | 0.00 | 0.00 |
| Basic Average Shares | 622.9M | 518.6M | 437.5M | 253.1M |
| Diluted Average Shares | 622.9M | 518.6M | 689.1M | 290.6M |
| Total Unusual Items | -4.5M | -983,000 | -204.00 | 1.1M |
| Total Unusual Items Excluding Goodwill | -4.5M | -983,000 | -204.00 | 1.1M |
| Tax Rate For Calcs | 0.00 | 0.00 | 0.26 | 0.18 |
| Normalized Income | 180,400 | -714,515 | 1.6M | -58,158 |
| Diluted NI Availto Com Stockholders | -4.3M | -1.7M | 1.6M | 823,113 |
| Gain On Sale Of Ppe | 0.00 | 25,000 | 0.00 | -- |
| Impairment Of Capital Assets | 4.5M | 1.0M | 0.00 | -467,558 |
| Insurance And Claims | 33,267 | 28,234 | 18,080 | 54,893 |
| Net Income Continuous Operations | -4.3M | -1.7M | 1.6M | 823,113 |
| Net Non Operating Interest Income Expense | -10,241 | -16,624 | 77,191 | -21,619 |
| Other Gand A | 193,062 | 234,068 | 291,982 | 253,556 |
| Other Special Charges | -40,000 | -- | -- | -614,044 |
| Other Taxes | -- | -- | -- | 0.00 |
| Reconciled Cost Of Revenue | 2.5M | 2.9M | 1.6M | 1.3M |
| Salaries And Wages | 797,910 | 614,319 | 548,327 | 326,316 |
| Total Expenses | 5.2M | 5.0M | 4.6M | 3.3M |
| Total Other Finance Cost | 2,249 | 1,691 | 2,692 | 1,815 |
| Line Item | FY 2024Dec 31, 2024 | FY 2023Dec 31, 2023 | FY 2022Dec 31, 2022 | FY 2021Dec 31, 2021 |
|---|---|---|---|---|
| Cash And Cash Equivalents | 1.1M | 227,974 | 4.3M | 145,605 |
| Cash Cash Equivalents And Short Term Investments | 1.1M | 227,974 | 4.3M | 145,605 |
| Cash Financial | 1.1M | 227,974 | 4.3M | 145,605 |
| Accounts Receivable | 333,969 | 235,692 | 354,357 | 516,818 |
| Receivables | 333,969 | 332,652 | 653,988 | 528,572 |
| Inventory | -- | -- | 0.00 | 9,755 |
| Prepaid Assets | 528,725 | 1.0M | 3.7M | 93,233 |
| Current Assets | 1.9M | 1.6M | 8.7M | 777,165 |
| Gross PPE | 44.8M | 37.9M | 31.8M | 26.0M |
| Accumulated Depreciation | -17.2M | -10.8M | -8.2M | -6.8M |
| Net PPE | 27.6M | 27.1M | 23.6M | 19.2M |
| Other Non Current Assets | -- | -- | -- | -2.00 |
| Total Non Current Assets | 27.6M | 27.1M | 23.6M | 19.2M |
| Total Assets | 29.6M | 28.7M | 32.3M | 20.0M |
| Current Debt | -- | 120,000 | -- | 399,405 |
| Current Debt And Capital Lease Obligation | -- | 120,000 | -- | 399,405 |
| Payables And Accrued Expenses | 2.0M | 1.7M | 2.8M | 1.8M |
| Other Current Liabilities | -- | 95,265 | 379,057 | 379,057 |
| Current Liabilities | 2.0M | 1.9M | 3.2M | 2.6M |
| Long Term Debt | -- | -- | 120,000 | 120,000 |
| Long Term Debt And Capital Lease Obligation | -- | -- | 120,000 | 120,000 |
| Other Non Current Liabilities | -- | -- | 93,583 | 463,269 |
| Total Non Current Liabilities Net Minority Interest | 3.1M | 2.2M | 2.9M | 3.4M |
| Total Liabilities Net Minority Interest | 5.1M | 4.0M | 6.1M | 6.0M |
| Common Stock | 33.5M | 30.0M | 29.8M | 19.2M |
| Capital Stock | 33.5M | 30.0M | 29.8M | 19.2M |
| Retained Earnings | -12.4M | -8.2M | -6.5M | -8.1M |
| Gains Losses Not Affecting Retained Earnings | 3.4M | 2.9M | 2.9M | 2.9M |
| Common Stock Equity | 24.5M | 24.7M | 26.2M | 14.0M |
| Stockholders Equity | 24.5M | 24.7M | 26.2M | 14.0M |
| Total Equity Gross Minority Interest | 24.5M | 24.7M | 26.2M | 14.0M |
| Total Capitalization | 24.5M | 24.7M | 26.4M | 14.1M |
| Net Tangible Assets | 24.5M | 24.7M | 26.2M | 14.0M |
| Tangible Book Value | 24.5M | 24.7M | 26.2M | 14.0M |
| Working Capital | -55,880 | -291,696 | 5.5M | -1.8M |
| Invested Capital | 24.5M | 24.8M | 26.4M | 14.5M |
| Total Debt | -- | 120,000 | 120,000 | 519,405 |
| Net Debt | -- | -- | -- | 373,800 |
| Share Issued | 623.5M | 519.6M | 517.3M | 303.2M |
| Ordinary Shares Number | 623.5M | 519.6M | 517.3M | 303.2M |
| Long Term Provisions | 3.1M | 2.2M | 2.7M | 2.7M |
| Non Current Deferred Liabilities | -- | -- | 0.00 | 186,294 |
| Non Current Deferred Taxes Liabilities | -- | -- | 0.00 | 186,294 |
| Other Current Borrowings | -- | 120,000 | -- | 399,405 |
| Other Properties | 3.2M | 2.9M | 2.7M | 2.0M |
| Properties | 41.6M | 35.0M | 29.1M | 24.1M |
| Taxes Receivable | 0.00 | 96,960 | 299,631 | 11,754 |
| Line Item | FY 2024Dec 31, 2024 | FY 2023Dec 31, 2023 | FY 2022Dec 31, 2022 | FY 2021Dec 31, 2021 |
|---|---|---|---|---|
| Operating Cash Flow | 2.2M | 1.4M | 2.2M | 953,810 |
| Cash Flow From Continuing Operating Activities | 2.2M | 1.4M | 2.2M | 953,810 |
| Depreciation And Amortization | 336,551 | 350,771 | 332,975 | 251,179 |
| Depreciation Amortization Depletion | 1.8M | 1.6M | 1.4M | 1.1M |
| Deferred Tax | -- | 0.00 | -186,294 | 186,294 |
| Deferred Income Tax | -- | 0.00 | -186,294 | 186,294 |
| Change In Working Capital | 152,096 | 432,066 | -653,782 | -251,531 |
| Changes In Account Receivables | -1,317 | 321,336 | -125,416 | -483,515 |
| Change In Receivables | -1,317 | 321,336 | -125,416 | -483,515 |
| Change In Inventory | -- | 0.00 | 9,755 | 5,044 |
| Change In Payables And Accrued Expense | 36,860 | 146,570 | -425,735 | 243,833 |
| Change In Payable | 36,860 | 146,570 | -425,735 | -- |
| Other Non Cash Items | 80,870 | 59,964 | 79,778 | 163,450 |
| Capital Expenditure | -274,499 | -234,840 | -757,060 | -2.5M |
| Purchase Of PPE | -274,499 | -234,840 | -757,060 | -2.5M |
| Net PPE Purchase And Sale | -274,499 | -164,840 | -757,060 | -2.5M |
| Investing Cash Flow | -5.4M | -5.3M | -8.3M | -2.5M |
| Cash Flow From Continuing Investing Activities | -5.4M | -5.3M | -8.3M | -2.5M |
| Issuance Of Debt | -- | -- | 0.00 | 399,405 |
| Net Issuance Payments Of Debt | -- | -- | 0.00 | 399,405 |
| Issuance Of Capital Stock | 4.2M | 0.00 | 10.7M | 1.5M |
| Net Common Stock Issuance | 4.2M | 0.00 | 10.7M | 1.5M |
| Financing Cash Flow | 4.0M | -249,355 | 10.3M | 1.6M |
| Cash Flow From Continuing Financing Activities | 4.0M | -249,355 | 10.3M | 1.6M |
| Changes In Cash | 858,476 | -4.1M | 4.2M | 43,094 |
| Beginning Cash Position | 227,974 | 4.3M | 145,605 | 102,511 |
| End Cash Position | 1.1M | 227,974 | 4.3M | 145,605 |
| Free Cash Flow | 2.0M | 1.2M | 1.5M | -1.6M |
| Asset Impairment Charge | 4.5M | 1.0M | 0.00 | -467,558 |
| Change In Account Payable | 36,860 | 146,570 | -425,735 | -- |
| Change In Prepaid Assets | 116,553 | -35,840 | -112,386 | -16,893 |
| Common Stock Issuance | 4.2M | 0.00 | 10.7M | 1.5M |
| Depletion | 1.5M | 1.3M | 1.1M | 862,907 |
| Depreciation | 336,551 | 350,771 | 332,975 | 251,179 |
| Gain Loss On Sale Of PPE | 0.00 | -25,000 | 0.00 | -- |
| Long Term Debt Issuance | -- | -- | 0.00 | 399,405 |
| Net Income From Continuing Operations | -4.3M | -1.7M | 1.6M | 823,113 |
| Net Long Term Debt Issuance | -- | -- | 0.00 | 399,405 |
| Net Other Financing Charges | -188,439 | -395,605 | -450,372 | -309,048 |
| Net Other Investing Changes | -5.1M | -5.1M | -7.6M | -- |
| Operating Gains Losses | -40,000 | -25,000 | -- | -614,044 |
| Proceeds From Stock Option Exercised | 0.00 | 146,250 | 0.00 | -- |
| Sale Of PPE | 0.00 | 70,000 | 0.00 | -- |